3eb58b511922fcbf…

{
  "id": "NCT00065767",
  "type": "Study",
  "data": {
    "briefSummary": "The aim of this study is to determine the effectiveness of treatment with raloxifene, an estrogen-like medication approved by the Food and Drug Administration for the treatment of osteoporosis, in improving memory and the ability to live independently in postmenopausal women with Alzheimer's disease.",
    "completionDate": "2005-03",
    "conditions": [
      "Alzheimer Disease"
    ],
    "enrollmentCount": 20,
    "enrollmentType": null,
    "nctId": "NCT00065767",
    "phase": "PHASE2, PHASE3",
    "sponsorId": "university-of-wisconsin-madison",
    "startDate": "2001-09",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease",
    "url": "https://clinicaltrials.gov/study/NCT00065767"
  }
}